View all reports
Revance Therapeutics, Inc. (RVNC) stock forecast and price target
Find the latest Revance Therapeutics, Inc. RVNC analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Date Range
investment rating
report type
sector
industry
provider
RVNCRevance Therapeutics, Inc.3.4000 +0.1100 (+3.34%)
At close: 08:00PM
Recommendation Rating
2.1
Analyst Price Targets (11)
Current 3.40
Average 14.91
Low 6.00
High 30.00
Related Research Reports1-1 of 1 results
| Report Name | Symbols | Sector | Provider | Date | |
|---|---|---|---|---|---|
| RILY,BW,JPM,CPNG,LAZR,TSN,RVNC,HSY,AVD,ATGE | Financial Services,Basic Materials,Healthcare,Industrials,Consumer Defensive,Consumer Cyclical | Argus | May 17, 2023 | Upgrade to begin downloading full reports |